PAM50 Genomic Test Anyone know if there are studies in U.S.?

Options

I read about an experimental genomic test that so far seems to sort women at risk of recurrence of cancer five years after diagnosis of Estrogen-Receptor-Positive cancer.  This could mean a shorter tx with estrogen-inhibitors if one is less at risk.

Does anyone know if there is research being done in the U.S. yet on this?

Categories